We are live on ! Find out more
AP

AtonRa Partners Portfolio holdings

AUM $50.2M
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$48.5M
Cap. Flow
+$27.1M
Cap. Flow %
9.94%
Top 10 Hldgs %
21.2%
Holding
121
New
13
Increased
46
Reduced
53
Closed
9

Top Buys

Rank Stock Value
1
SEDG icon
SolarEdge
SEDG
+$3.1M
2
MRVL icon
Marvell Technology
MRVL
+$3.02M
3
VEEV icon
Veeva Systems
VEEV
+$2.97M
4
QTRX icon
Quanterix
QTRX
+$2.96M
5
SOFI icon
SoFi Technologies
SOFI
+$2.56M

Top Sells

Rank Stock Value
1
GH icon
Guardant Health
GH
+$2.98M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.86M
3
ILMN icon
Illumina
ILMN
+$2.18M
4
RGNX icon
Regenxbio
RGNX
+$2.05M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.77M

Sector Composition

Rank Sector Weight
1 Technology 44.35%
2 Healthcare 32.32%
3 Financials 8.79%
4 Industrials 7.11%
5 Consumer Discretionary 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECL icon
51
Ecolab
ECL
$75.6B
$2.56M 0.94%
12,417
+6,969
+128% +$1.51M
BIDU icon
52
Baidu
BIDU
$35.8B
$2.48M 0.91%
12,145
-551
-4% -$110K
SHOP icon
53
Shopify
SHOP
$148B
$2.3M 0.84%
+15,720
New +$1.94M
ABT icon
54
Abbott
ABT
$180B
$2.27M 0.83%
19,580
-862
-4% -$100K
FSLR icon
55
First Solar
FSLR
$21.8B
$2.25M 0.82%
24,800
+14,219
+134% +$1.13M
CRNC icon
56
Cerence
CRNC
$382M
$2.24M 0.82%
20,982
-129
-0.6% -$12.7K
IQV icon
57
IQVIA
IQV
$34.7B
$2.23M 0.82%
9,191
+53
+0.6% +$12.2K
TENB icon
58
Tenable Holdings
TENB
$3.56B
$2.11M 0.78%
+51,120
New +$2.07M
CTLT
59
DELISTED
CATALENT, INC.
CTLT
$2.08M 0.76%
+19,190
New +$2.06M
TTEK icon
60
Tetra Tech
TTEK
$8.23B
$2.06M 0.75%
84,295
+47,865
+131% +$1.2M
PLTR icon
61
Palantir
PLTR
$295B
$2.03M 0.74%
76,949
-2,421
-3% -$56K
PACB icon
62
Pacific Biosciences
PACB
$422M
$2.02M 0.74%
57,724
+30,943
+116% +$900K
FATE icon
63
Fate Therapeutics
FATE
$281M
$2.01M 0.74%
23,211
+1,344
+6% +$108K
FOUR icon
64
Shift4
FOUR
$3.84B
$1.74M 0.64%
18,612
+106
+0.6% +$10K
MAXR
65
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$1.66M 0.61%
41,610
-20,147
-33% -$717K
TWST icon
66
Twist Bioscience
TWST
$5.62B
$1.59M 0.58%
11,921
+1,247
+12% +$145K
DT icon
67
Dynatrace
DT
$12.1B
$1.52M 0.56%
26,109
-457
-2% -$23.9K
OKTA icon
68
Okta
OKTA
$24.1B
$1.52M 0.56%
6,217
-226
-4% -$54.5K
TRMB icon
69
Trimble
TRMB
$12.3B
$1.48M 0.54%
18,118
-1,812
-9% -$144K
INSP icon
70
Inspire Medical Systems
INSP
$1.42B
$1.42M 0.52%
7,326
+120
+2% +$23.8K
FISV
71
Fiserv Inc
FISV
$27.2B
$1.42M 0.52%
13,238
-622
-4% -$72.3K
ALNY icon
72
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.37M 0.5%
8,097
-12,113
-60% -$1.77M
SNOW icon
73
Snowflake
SNOW
$92.9B
$1.35M 0.5%
5,598
-34
-0.6% -$7.91K
AXNX
74
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.34M 0.49%
21,218
-1,062
-5% -$62.7K
EW icon
75
Edwards Lifesciences
EW
$47.6B
$1.31M 0.48%
12,617
-830
-6% -$78.2K
1 2
3
4 5

Similar funds

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
SC
Sonen Capital San Francisco, California $52.7M AUM 25.58% 1-Year Est. Return
AOGP
Addition One General Partner New York $45.7M AUM
ACJ
Autonomy Capital (Jersey) St. Helier, Jersey $54.8M AUM 37.27% 1-Year Est. Return
UFG
United Fire Group Cedar Rapids, Iowa $55M AUM 6% 1-Year Est. Return
KC
Kellner Capital New York $55.5M AUM 88.05% 1-Year Est. Return
P
Pariax Newport Beach, California $44.3M AUM 12.57% 1-Year Est. Return
AMC
AKKR Management Company Menlo Park, California $42.5M AUM 123.1% 1-Year Est. Return

AtonRa Partners's Q2 2021 Portfolio in Review

As of Q2 2021, AtonRa Partners held 121 positions worth $273M, up 22% from $224M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

AtonRa Partners deployed $27.1M of net new capital in Q2 2021, opening 13 new positions and adding to 46 existing holdings. Its largest new stake was Marvell Technology: 61,809 shares worth $3.6M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 41% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Guardant Health, an estimated $2.98M trimmed.

  • AtonRa Partners's largest Q2 2021 buy was Marvell Technology: 61,809 shares worth $3.6M.
  • AtonRa Partners added most to SolarEdge in Q2 2021, an estimated $3.1M increase.
  • AtonRa Partners's biggest Q2 2021 reduction was Guardant Health, cutting an estimated $2.98M.
  • AtonRa Partners fully exited Vertex Pharmaceuticals in Q2 2021, selling an estimated $2.86M.
  • AtonRa Partners's ten largest holdings make up 21% of its $273M portfolio in Q2 2021.
  • AtonRa Partners opened 13 new positions and closed 9 in Q2 2021.
  • AtonRa Partners's portfolio value rose 22% quarter-over-quarter to $273M.

Based on AtonRa Partners's 13F filing for Q2 2021, filed 12 Aug 2021.